Adenoviral gene transfer of a single-chain IL-23 induces psoriatic arthritis-like symptoms in NOD mice.
adenovirus
interleukin-17
interleukin-23
psoriasis
type 1 diabetes
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
pubmed:
7
6
2019
medline:
2
6
2020
entrez:
7
6
2019
Statut:
ppublish
Résumé
Previously, we demonstrated that intratumoral delivery of adenoviral vector encoding single-chain (sc)IL-23 (Ad.scIL-23) was able to induce systemic antitumor immunity. Here, we examined the role of IL-23 in diabetes in nonobese diabetic mice. Intravenous delivery of Ad.scIL-23 did not accelerate the onset of hyperglycemia but instead resulted in the development of psoriatic arthritis. Ad.scIL-23-treated mice developed erythema, scales, and thickening of the skin, as well as intervertebral disc degeneration and extensive synovial hypertrophy and loss of articular cartilage in the knees. Immunological analysis revealed activation of conventional T helper type 17 cells and IL-17-producing γδ T cells along with a significant depletion and suppression of T cells in the pancreatic lymph nodes. Furthermore, treatment with anti-IL-17 antibody reduced joint and skin psoriatic arthritis pathologies. Thus, these Ad.scIL-23-treated mice represent a physiologically relevant model of psoriatic arthritis for understanding disease progression and for testing therapeutic approaches.-Flores, R. R., Carbo, L., Kim, E., Van Meter, M., De Padilla, C. M. L., Zhao, J., Colangelo, D., Yousefzadeh, M. J., Angelini, L. A., Zhang, L., Pola, E., Vo, N., Evans, C. H., Gambotto, A., Niedernhofer, L. J., Robbins, P. D. Adenoviral gene transfer of a single-chain IL-23 induces psoriatic arthritis-like symptoms in NOD mice.
Identifiants
pubmed: 31170010
doi: 10.1096/fj.201900420R
pmc: PMC6662986
doi:
Substances chimiques
Interleukin-17
0
Interleukin-23
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9505-9515Références
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11874-8
pubmed: 8524866
J Immunol. 2006 May 1;176(9):5652-61
pubmed: 16622035
Cancer Gene Ther. 2012 Feb;19(2):135-43
pubmed: 22158522
J Invest Dermatol. 2001 Sep;117(3):618-26
pubmed: 11564168
N Engl J Med. 2005 May 5;352(18):1899-912
pubmed: 15872205
J Clin Invest. 2006 Aug;116(8):2094-104
pubmed: 16886058
J Autoimmun. 2017 Jan;76:21-37
pubmed: 27836567
Diabetes. 2000 Jul;49(7):1106-15
pubmed: 10909966
Blood. 1995 Oct 15;86(8):3220-6
pubmed: 7579418
Am J Pathol. 1999 Jul;155(1):145-58
pubmed: 10393847
J Clin Invest. 2004 Feb;113(3):451-63
pubmed: 14755342
Nat Med. 2009 Sep;15(9):1013-5
pubmed: 19684581
Nat Immunol. 2011 Mar;12(3):255-63
pubmed: 21278737
J Invest Dermatol. 2013 Jan;133(1):164-71
pubmed: 22895364
Clin Exp Immunol. 2015 Dec;182(3):261-9
pubmed: 26250153
J Immunol. 2003 Jun 1;170(11):5491-501
pubmed: 12759426
J Immunol. 2011 Apr 1;186(7):4481-9
pubmed: 21346238
J Exp Med. 2006 Nov 27;203(12):2577-87
pubmed: 17074928
Cancer Gene Ther. 1999 Jan-Feb;6(1):45-53
pubmed: 10078963
Science. 1965 Jun 11;148(3676):1471-3
pubmed: 17738154
J Invest Dermatol. 2009 Feb;129(2):355-8
pubmed: 18800148
Arthritis Res Ther. 2012 Mar 14;14(2):R65
pubmed: 22417743
Eur J Immunol. 2015 Nov;45(11):3114-25
pubmed: 26260044
J Exp Med. 2004 Mar 1;199(5):731-6
pubmed: 14981113
Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S14-9
pubmed: 26472560
Nat Med. 2005 Jan;11(1):43-9
pubmed: 15592573
J Orthop Res. 2010 Dec;28(12):1600-7
pubmed: 20973062
Clin Rev Allergy Immunol. 2016 Jun;50(3):377-89
pubmed: 27025861
J Immunol. 2015 Jan 1;194(1):68-75
pubmed: 25480564
Cytokine. 2015 Feb;71(2):366-76
pubmed: 25510901
J Biol Chem. 2003 Jan 17;278(3):1910-4
pubmed: 12417590
J Invest Dermatol. 1990 Nov;95(5 Suppl):62S-63S
pubmed: 16788637
Pathobiology. 1997;65(5):271-86
pubmed: 9459497
J Dermatol. 2010 May;37(5):413-25
pubmed: 20536646
Wien Klin Wochenschr. 2016 Nov;128(21-22):791-795
pubmed: 27822746
Clin Exp Immunol. 2016 Jan;183(1):16-29
pubmed: 26102289
J Immunol. 2003 Jun 1;170(11):5438-44
pubmed: 12759419
J Immunol. 2003 Oct 1;171(7):3333-7
pubmed: 14500624
J Invest Dermatol. 1994 May;102(5):781-8
pubmed: 8176263
Nat Immunol. 2012 Jul 19;13(8):722-8
pubmed: 22814351
Immunity. 2000 Nov;13(5):643-55
pubmed: 11114377
Annu Rev Immunol. 2014;32:227-55
pubmed: 24655295
PLoS One. 2013 Dec 27;8(12):e84634
pubmed: 24386404
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
J Immunol. 2006 Feb 1;176(3):1908-15
pubmed: 16424222
J Immunol. 2008 Oct 1;181(7):4733-41
pubmed: 18802076
Nature. 2002 Jun 20;417(6891):861-6
pubmed: 12075355
Gene Ther. 2003 Oct;10(21):1821-9
pubmed: 12960972
Cancer Gene Ther. 2009 Oct;16(10):776-85
pubmed: 19390568
J Rheumatol. 2012 Feb;39(2):418-20
pubmed: 22298270
Nature. 2007 Feb 8;445(7128):648-51
pubmed: 17187052
Clin Exp Immunol. 2016 Mar;183(3):380-8
pubmed: 26496462
J Clin Invest. 2009 Aug;119(8):2317-29
pubmed: 19662682
J Invest Dermatol. 2004 Mar;122(3):665-9
pubmed: 15086551
J Autoimmun. 2001 Mar;16(2):97-104
pubmed: 11247635
Cell Res. 2002 Mar;12(1):19-32
pubmed: 11942407
Eur J Immunol. 2010 Aug;40(8):2236-47
pubmed: 20458705
Science. 1995 May 26;268(5214):1185-8
pubmed: 7761837
N Engl J Med. 2010 Jan 14;362(2):118-28
pubmed: 20071701
J Immunol. 2010 Aug 1;185(3):1959-67
pubmed: 20592279
Blood. 2003 Jul 1;102(1):161-8
pubmed: 12649136
Biotechnol Prog. 2004 Mar-Apr;20(2):443-8
pubmed: 15058988
J Immunol. 2011 Feb 1;186(3):1495-502
pubmed: 21172868
Exp Dermatol. 2006 Jun;15(6):461-8
pubmed: 16689863
EMBO J. 2004 Apr 21;23(8):1770-81
pubmed: 15057277
J Immunol. 2010 Nov 15;185(10):5688-91
pubmed: 20956338
Cell. 2006 Sep 22;126(6):1121-33
pubmed: 16990136